Minster Pharmaceuticals plc
About Minster Pharmaceuticals
Minster Pharmaceuticals is a drug development company focussed on neurological and psychiatric disorders. Its principal pipeline assets are tonabersat and sabcomeline. Worldwide rights to both compounds were acquired from GlaxoSmithKline and the compounds benefit from comprehensive safety tolerance data as a result of investment by GSK.
Facts about Minster Pharmaceuticals
Facts about Minster Pharmaceuticals
- Industry : Pharma